The ERA-NET TRANSCAN-2 project successfully closed on June 30th, 2021 

The action is continuing with the ERA-NET TRANSCAN-3: Sustained collaboration of national and regional programmes in cancer research, funded by the European Commission under Horizon 2020 from 2021 to 2026 (Grant Agreement no. 964264).

TRANSCAN-3 preannounces the launch of its second call for proposals (JTC 2022) on the topic:

 "Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy"  

For more info please visit the new TRANSCAN-3 website at:

and follow us on: twitter logoinkedin social media logo

Some of the TRANSCAN-2 funded projects are still ongoing and the individual project webpages will be continuously updated.


The ERA-NET: Aligning national/regional translational cancer research programmes and activities - TRANSCAN-2 is a project funded by the European Commission under the EU framework programme Horizon2020 (Grant Agreement no. 643638) from 2015 to 2021.

It is the continuation of the previous ERA-NET on translational cancer research TRANSCAN, funded under the FP7 from 2011 to 2014.

TRANSCAN-2 is a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research. The network is composed of 31 partners from 19 Countries.

The project is coordinated by the Ministry of Health, Italy
Coordinator: Dr. Giovanni Leonardi. Deputy coordinator: Dr. Gaetano Guglielmi

Dr. Silvia Paradisi
Project Manager
Italian National Institute of Health
Viale Regina Elena, 299
00161 Rome, Italy
mail to: This email address is being protected from spambots. You need JavaScript enabled to view it.